276 related articles for article (PubMed ID: 8104853)
21. [Atenolol or metoprolol as beta-blocker in the treatment of hypertension].
van den Born BJ; Brewster LM; Koopmans RP; van Montfrans GA
Ned Tijdschr Geneeskd; 2005 Aug; 149(32):1808-9. PubMed ID: 16121668
[TBL] [Abstract][Full Text] [Related]
22. Are tolerability concerns a class effect of beta-blockers in treating patients with hypertension?
Kountz DS
Postgrad Med; 2009 Jan; 121(1):14-24. PubMed ID: 19179810
[TBL] [Abstract][Full Text] [Related]
23. Cardiovascular protection using beta-blockers: a critical review of the evidence.
Bangalore S; Messerli FH; Kostis JB; Pepine CJ
J Am Coll Cardiol; 2007 Aug; 50(7):563-72. PubMed ID: 17692739
[TBL] [Abstract][Full Text] [Related]
24. Effects of antihypertensive treatment with beta-blockers on glucose metabolism.
Sawicki PT; Berger M
J Cardiovasc Pharmacol; 1992; 20 Suppl 11():S45-7; discussion S47-8. PubMed ID: 1284143
[TBL] [Abstract][Full Text] [Related]
25. Beta-blockers as antiarrhythmic agents.
Zicha S; Tsuji Y; Shiroshita-Takeshita A; Nattel S
Handb Exp Pharmacol; 2006; (171):235-66. PubMed ID: 16610347
[TBL] [Abstract][Full Text] [Related]
26. Pharmacology of beta-blockers: classical aspects and recent developments.
Haeusler G
J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S1-9. PubMed ID: 11527109
[TBL] [Abstract][Full Text] [Related]
27. The 2004 Canadian recommendations for the management of hypertension: Part II--Therapy.
Khan NA; McAlister FA; Campbell NR; Feldman RD; Rabkin S; Mahon J; Lewanczuk R; Zarnke KB; Hemmelgarn B; Lebel M; Levine M; Herbert C;
Can J Cardiol; 2004 Jan; 20(1):41-54. PubMed ID: 14968142
[TBL] [Abstract][Full Text] [Related]
28. [Do beta-blockers prevent coronary events in hypertensive patients?].
Diévart F; Ragot S; Julien J; Herpin D
Arch Mal Coeur Vaiss; 2005 Sep; 98(9):881-8. PubMed ID: 16231574
[TBL] [Abstract][Full Text] [Related]
29. [Treatment of hypertension: angiotensin-II antagonists potentially better than beta-blockers in the occurrence of cardiovascular and cerebrovascular damage; the LIFE study in perspective].
de Boer RA; van Veldhuisen DJ; Gans RO; Gansevoort RT
Ned Tijdschr Geneeskd; 2003 Jan; 147(3):96-9. PubMed ID: 12577767
[TBL] [Abstract][Full Text] [Related]
30. Pulmonary effects of nebivolol.
Dal Negro R
Ther Adv Cardiovasc Dis; 2009 Aug; 3(4):329-34. PubMed ID: 19638367
[TBL] [Abstract][Full Text] [Related]
31. [Isolated systolic hypertension. "AT1 blocker preferred over beta-blocker"].
MMW Fortschr Med; 2002 Sep; 144(38):14. PubMed ID: 12395694
[No Abstract] [Full Text] [Related]
32. Beta-blocker underuse in secondary prevention of myocardial infarction.
Everly MJ; Heaton PC; Cluxton RJ
Ann Pharmacother; 2004 Feb; 38(2):286-93. PubMed ID: 14742768
[TBL] [Abstract][Full Text] [Related]
33. A meta-analysis of 94,492 patients with hypertension treated with beta blockers to determine the risk of new-onset diabetes mellitus.
Bangalore S; Parkar S; Grossman E; Messerli FH
Am J Cardiol; 2007 Oct; 100(8):1254-62. PubMed ID: 17920367
[TBL] [Abstract][Full Text] [Related]
34. Beta-blockers in hypertensive and coronary heart disease.
Goldstein S
Arch Intern Med; 1996 Jun; 156(12):1267-76. PubMed ID: 8651834
[TBL] [Abstract][Full Text] [Related]
35. Randomized controlled trial of ACE-inhibitors and beta-blockers with and without vasodilating activity in chronic glomerulonephritis.
Erley CM; Klass M; Krämer D; Berger E; Heyne N; Braun N; Wolf S; Risler T
Int J Clin Pharmacol Ther; 1996 Nov; 34(11):504-9. PubMed ID: 8937934
[TBL] [Abstract][Full Text] [Related]
36. [Comparison beta-blockers and their relevance to pharmacologic therapy of cardiovascular diseases].
Wehling M
Arzneimittelforschung; 2002; 52(2):73-80. PubMed ID: 11878202
[TBL] [Abstract][Full Text] [Related]
37. Atenolol as initial antihypertensive therapy: an observational study comparing first-line agents.
Blackburn DF; Lamb DA; Eurich DT; Johnson JA; Wilson TW; Dobson RT; Blackburn JL
J Hypertens; 2007 Jul; 25(7):1499-505. PubMed ID: 17563574
[TBL] [Abstract][Full Text] [Related]
38. [Clinical aspects of use of beta-blockers in the treatment of arterial hypertension].
Widimský J
Vnitr Lek; 1997 Apr; 43(4):221-5. PubMed ID: 9601840
[TBL] [Abstract][Full Text] [Related]
39. Mechanistic and clinical rationales for using beta-blockers in heart failure.
Bristow MR
J Card Fail; 2000 Jun; 6(2 Suppl 1):8-14. PubMed ID: 10908093
[TBL] [Abstract][Full Text] [Related]
40. Beta-blockers in the treatment of hypertension: are there clinically relevant differences?
Weir MR
Postgrad Med; 2009 May; 121(3):90-8. PubMed ID: 19491545
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
